Document
IPR2020-01320, No. 3 Petition - Petition for Inter Partes Review (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01320, No. 3 Petition - Petition for Inter Partes Review (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01317, No. 3 Petition - Petition for Inter Partes Review (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01317, No. 3 Petition - Petition for Inter Partes Review (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01318, No. 5 Notice - Petitioners Updated Mandatory Notices Pursuant to 37 CFR 428 (P.T.A.B. Jul. 28, 2020)
Cite Document
IPR2020-01318, No. 5 Notice - Petitioners Updated Mandatory Notices Pursuant to 37 CFR 428 (P.T.A.B. Jul. 28, 2020)
+ More Snippets
Document
IPR2020-01318, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01318, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01318, No. 2 Notice - Petitioners Notice of Ranking Petitions (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01318, No. 2 Notice - Petitioners Notice of Ranking Petitions (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01317, No. 16 Rehearing Request in re Petition Institution Decision Denied - Petitioners Request for Rehearing (P.T.A.B. Feb. 12, 2021)
Cite Document
IPR2020-01317, No. 16 Rehearing Request in re Petition Institution Decision Denied - Petitioners Request for Rehearing (P.T.A.B. Feb. 12, 2021)
+ More Snippets
Document
IPR2020-01317, No. 10 Preliminary Response - Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporations Patent Owner Preliminary Response (P.T.A.B. Oct. 2...
Cite Document
IPR2020-01317, No. 10 Preliminary Response - Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporations Patent Owner Preliminary Response (P.T.A.B. Oct. 22, 2020)
+ More Snippets
Document
IPR2020-01317, No. 11 Response - Patent Owners Response to Petitioners Notice Ranking Petitions (P.T.A.B. Oct. 22, 2020)
Cite Document
IPR2020-01317, No. 11 Response - Patent Owners Response to Petitioners Notice Ranking Petitions (P.T.A.B. Oct. 22, 2020)
+ More Snippets
Document
IPR2020-01317, No. 6 Mandatory Notice - Patent Owners Submission of Mandatory Notice Information Under 37 CFR s 428a2 (P.T.A.B. Aug. 6, 2020)
Cite Document
IPR2020-01317, No. 6 Mandatory Notice - Patent Owners Submission of Mandatory Notice Information Under 37 CFR s 428a2 (P.T.A.B. Aug. 6, 2020)
+ More Snippets
Document
IPR2020-01317, No. 9 Power of Attorney - Patent Owner Novartis Technology LLCs Power of Attorney (P.T.A.B. Aug. 6, 2020)
Cite Document
IPR2020-01317, No. 9 Power of Attorney - Patent Owner Novartis Technology LLCs Power of Attorney (P.T.A.B. Aug. 6, 2020)
+ More Snippets
Document
IPR2020-01317, No. 8 Power of Attorney - Patent Owner Novartis Pharmaceuticals Corporations Power of Attorney (P.T.A.B. Aug. 6, 2020)
Cite Document
IPR2020-01317, No. 8 Power of Attorney - Patent Owner Novartis Pharmaceuticals Corporations Power of Attorney (P.T.A.B. Aug. 6, 2020)
+ More Snippets
Document
IPR2020-01317, No. 7 Power of Attorney - Patent Owner Novartis Pharma AGs Power of Attorney (P.T.A.B. Aug. 6, 2020)
Cite Document
IPR2020-01317, No. 7 Power of Attorney - Patent Owner Novartis Pharma AGs Power of Attorney (P.T.A.B. Aug. 6, 2020)
+ More Snippets
Document
IPR2020-01320, No. 2 Notice - Petitioners Notice Ranking Petitions (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01320, No. 2 Notice - Petitioners Notice Ranking Petitions (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01320, No. 1 Power of Attorney - Power of Attorney for Petitioner Regeneron Pharmaceuticals, Inc (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01320, No. 1 Power of Attorney - Power of Attorney for Petitioner Regeneron Pharmaceuticals, Inc (P.T.A.B. Jul. 16, 2020)
+ More Snippets
Document
IPR2020-01317, No. 1 Power of Attorney - Power of Attorney for Petitioner Regeneron Pharmaceuticals, Inc (P.T.A.B. Jul. 16, 2020)
Cite Document
IPR2020-01317, No. 1 Power of Attorney - Power of Attorney for Petitioner Regeneron Pharmaceuticals, Inc (P.T.A.B. Jul. 16, 2020)
+ More Snippets